Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Mohali 160 062, Punjab, India.
Drug Test Anal. 2009 Aug;1(8):372-81. doi: 10.1002/dta.75.
It is claimed that ayurvedic/herbal healthcare products (AHPs) are safe because of their natural origin. However, several reports exist of adulteration of AHPs with synthetic drugs. In this study, a generalized strategy was developed using LC-MS/TOF for the detection and verification of steroidal and anti-inflammatory drugs in 58 AHPs collected from various parts of India. The strategy involved recording of mass spectral information for standard drugs-including ionization mode (ESI/APCI - ve or + ve), mass spectrum, accurate mass, identification of qualifier fragments (two), extracted ion chromatograms (EICs), isotopic pattern and determination of UV max (nm)-through UV-PDA studies. Adulteration was then detected in AHPs primarily through comparison of EICs at accurate m/z for molecular ion peaks and R(T) matching with the standard. It was confirmed by spiking with the standards, and matching mass spectrum, accurate mass, R(T) of qualifier fragments, isotopic pattern and UV spectrum of the standards with the adulterant peaks in AHPs. Dexamethasone and diclofenac were detected as adulterants in ten AHPs whereas one AHP tested positive for piroxicam and another for dexamethasone. All the adulterated products were sold by the healthcare practitioners, while no product marketed by manufacturers or chemist shops had this problem. The study showed that LC-MS/TOF-based screening could be used as a rapid approach to monitor adulteration of steroids and anti-inflammatory drugs in AHPs.
据称,由于源自天然,阿育吠陀/草药保健品 (AHPs) 是安全的。然而,有几例报告显示,AHPs 被掺假掺入了合成药物。在这项研究中,开发了一种使用 LC-MS/TOF 的广义策略,用于检测和验证从印度各地收集的 58 种 AHPs 中的甾体和抗炎药物。该策略涉及记录标准药物的质谱信息 - 包括电离模式(ESI/APCI- 或 + )、质谱、精确质量、鉴定定性碎片(两个)、提取离子色谱图(EICs)、同位素模式和确定 UV max(nm)- 通过 UV-PDA 研究。然后主要通过比较 AHPs 中准确 m/z 的分子离子峰的 EIC 以及与标准品的 R(T) 匹配来检测掺假。通过用标准品进行加标以及匹配标准品的质谱、精确质量、定性碎片的 R(T)、同位素模式和 UV 光谱来确认掺假峰。在十种 AHPs 中检测到地塞米松和双氯芬酸作为掺杂物,而一种 AHP 测试出吡罗昔康阳性,另一种 AHP 测试出地塞米松阳性。所有掺假产品均由医疗保健从业者销售,而制造商或药店销售的产品均无此问题。该研究表明,基于 LC-MS/TOF 的筛选可作为快速监测 AHPs 中类固醇和抗炎药物掺假的方法。